Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  tirapazamine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-19 of 19 for your search:
Start Over
Phase III Randomized Study of Carboplatin and Paclitaxel With or Without Tirapazamine in Patients With Advanced Non-Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-S0003, S0003, NCT00006484
Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EFC4690, SR259075, NCT00094081
TRACE: Tirapazamine-Radiation And Cisplatin Evaluation
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EFC5512, SR259075, NCT00174837
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00591, CAN-NCIC-GOG-0219, CDR0000455555, GOG-0219, U10CA027469, NCT00262821
Phase I/II Study of Tirapazamine plus CDDP in Stage IV or Recurrent Cervical Cancer (Summary Last Modified 09/95)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-94082, NCI-V94-0542
Phase I/II Open Label, Dose Escalation Study of Combination Chemotherapy With Intravenously Administered Tirapazamine, Cisplatin, and Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-96062, SANOFI-EFC3031, NCI-G97-1235
Phase II Study of Radiotherapy with Tirapazamine Radiosensitization for Glioblastoma Multiforme (Summary Last Modified 01/99)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: RTOG-9417, RTOG-94-17
Phase II Study of Tirapazamine/Cisplatin for Previously Untreated Stage IIIB/IV non-Small Cell Lung Cancer (Summary Last Modified 07/96)
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-94114A1, NCI-V95-0659
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 17
Sponsor: NCI, Other
Protocol IDs: IRB-12503, CA67166, NCI-T94-0119O, CDR0000064752, SQL 72951, SUMC-OP-003, T94-0119, NCT00002774
Phase II Study of Tirapazamine and Cisplatin in Patients With Persistent or Recurrent Platinum-Sensitive Ovarian Epithelial or Primary Peritoneal Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: GOG-0146M, NCT00020696
Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Under 21 at time of initial diagnosis
Sponsor: NCI
Protocol IDs: NCI-2012-01864, ARST0121, U10CA098543, CDR0000068954, COG-ARST0121, NCT00025363
Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03042, U10CA032102, S0222, SWOG-S0222, NCT00066742
S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066358, SWOG-S9717, U10CA032102, S9717, NCT00003369
Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-01837, POG-9675, CDR0000066219, NCT00003288
Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 99139, U01CA062505, P30CA033572, CHNMC-PHI-22, CHNMC-IRB-99139, NCI-T99-0068, CDR0000067685, T99-0068, NCT00005078
S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068318, U10CA032102, S0004, SWOG-S0004, NCT00006487
Phase I Study of Tirapazamine, Paclitaxel, and Carboplatin With Concurrent Radiotherapy in Patients With Stage IIB-IIIB Non-Small Cell Lung Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCC-PHI-31, CHNMC-PHI-31, NCI-571, NCT00033410, 571
Start Over